Abiopharma

New Form 8-K - U S PHYSICAL THERAPY INC /NV Filed: 2025-08-11 AccNo: 0000885978-25-000044 Size: 406 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - BIOVIE INC. Filed: 2025-08-11 AccNo: 0001520138-25-000249 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Biofrontera Notification (BFRI)

New Form 4 - ORASURE TECHNOLOGIES INC Filed: 2025-08-11 AccNo: 0001062993-25-014059 Size: 4 KB

Biofrontera Inc. Appoints George Jones as Chief Commercial Officer

New Form 4 - KORU Medical Systems, Inc. Filed: 2025-08-11 AccNo: 0001161697-25-000246 Size: 11 KB

New Form 8-K - Longeveron Inc. Filed: 2025-08-11 AccNo: 0001213900-25-074318 Size: 956 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - KORU Medical Systems, Inc. Filed: 2025-08-11 AccNo: 0001161697-25-000245 Size: 7 KB

New Form 144 - RHYTHM PHARMACEUTICALS, INC. Filed: 2025-08-11 AccNo: 0001950047-25-005616 Size: 5 KB

New Form 4 - Claritev Corp Filed: 2025-08-11 AccNo: 0001793229-25-000140 Size: 5 KB

New Form 144 - iRhythm Technologies, Inc. Filed: 2025-08-11 AccNo: 0001950047-25-005613 Size: 5 KB

New Form 144 - Royalty Pharma plc Filed: 2025-08-11 AccNo: 0001964306-25-000309 Size: 4 KB

New Form 144 - BridgeBio Pharma, Inc. Filed: 2025-08-11 AccNo: 0001950047-25-005610 Size: 7 KB

New Form ARS - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-08-11 AccNo: 0001437749-25-025936 Size: 2 MB

New Form 8-K - Inspire Medical Systems, Inc. Filed: 2025-08-11 AccNo: 0001609550-25-000035 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits